SESTD1 as a potential prognostic biomarker associated with tumor aggressiveness and immune infiltration in hepatocellular carcinoma
SESTD1 may serve as a diagnostic and prognostic marker, as well as a potential target for immunotherapy in HCC.
Authors
- Hao Cheng (ORCID: https://orcid.org/0000-0003-1031-8357)
- Li Tang (ORCID: https://orcid.org/0000-0002-6776-1846)
- Jiaoxiang Wu (ORCID: https://orcid.org/0000-0002-2309-4164)
- Tianhui Chen (ORCID: https://orcid.org/0000-0003-4677-0361)
- Ying Liu (ORCID: https://orcid.org/0000-0001-9385-992X)
- Ming Xu (ORCID: https://orcid.org/0009-0005-1536-8427)
- Bo Han (ORCID: https://orcid.org/0000-0002-8633-7661)
- Liang Yu (ORCID: https://orcid.org/0009-0007-3922-3454)
- Sheng Cheng (ORCID: https://orcid.org/0000-0001-9916-3405)
- Bingyan Liu (ORCID: https://orcid.org/0009-0005-4207-2947)
- Daqing Cheng
Institutions
- Guizhou University (CN)
- Shanghai Jiao Tong University (CN)
- Gansu University of Traditional Chinese Medicine (CN)
- Tongren Hospital (CN)
- Guiyang University (CN)
- Community Health Center (US)
Publication Details
- Journal
- Clinics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.clinsp.2025.100796
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00